Zimmer Biomet (NYSE: ZBH) and Getinge announced today announced a strategic partnership related to ambulatory surgical centers (ASCs).
Under the partnership, Zimmer Biomet agreed to distribute Getinge’s operating room (OR) capital products to its ASC customers. The partnership creates a turnkey solution for ASC customers. Now, they can access Getinge’s infection control and surgical portfolio and Zimmer Biomet’s array of implants and surgical robotic offerings from a single source.
Zimmer Biomet says the partnership comes as ASCs continue to grow as a major piece of the U.S. healthcare landscape. It can now offer Getinge’s surgical equipment, OR integration and lighting alongside its own leading implants and technologies.
“For us, this partnership represents a significant advancement in our efforts to innovate and expand the boundaries of healthcare. We are thrilled to collaborate with Zimmer Biomet to deliver value to healthcare professionals and patients within the orthopedic ASC sector. This collaboration shows our commitment to making life-saving technology accessible to more people,” said Patricia Fitch, president of North America at Getinge.
The companies plan to implement the partnership in phases, starting in the U.S. Eventually, they expect to offer their combined portfolio of ASC solutions in additional global regions.
“Together with Getinge, we’re expanding our ability to deliver a comprehensive, turnkey solution for our ASC customers – faster and more seamlessly – from a company they know and trust,” said Jehanzeb Noor, SVP, chief strategy, innovation and business development officer, Zimmer Biomet. “As orthopedic surgeries increasingly migrate from traditional hospital settings to ASCs, the imperative to drive efficiency, enhance patient safety, and improve clinical outcomes has never been greater. By aligning with Getinge, we’re accelerating our ability to support surgeons in advancing these priorities, while shaping the future of orthopedic care.”
